Getting to Know GU
from Dr. Chris Wallis
Latest in Perioperative RCC Treatment – Part 2
On this episode, Dr. Wallis speaks with Dr. Aly-Khan Lalani to talk about perioperative treatment for Renal Cell Carcinoma (RCC), why referral pathways are critical, and what we can learn from future critical trials in this space.
Learning Objectives:
- Explore the referral pathways doctors can take to help facilitate care.
Speaker Disclosures: (Honoraria, Consulting or Advisory Role, Research Funding)
Dr. Lalani: AbbVie, Astellas, AstraZeneca, Bayer, BioCanRx, BMS, Eisai, EMD Serono, Ipsen, Janssen, McKesson, Merck, Novartis, Pfizer, Roche, TerSera.
Disclaimer:
“Getting to Know GU” is a Podcast, (Other Learning Activity) sponsored by Bayer Inc., intended for Healthcare Professionals interested and/or working in Urology & GU Oncology. Full editorial control of this program’s content resides with the speaker(s). Statements of fact and opinions expressed are those of the speaker(s) and do not necessarily reflect the opinions or position of Bayer Inc.
In accordance with the Innovative Medicines Canada Code of Ethical Practices, this program is limited to Healthcare Professionals.
PP-PF-ONC-CA-0056-1